155 related articles for article (PubMed ID: 20230782)
21. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
[TBL] [Abstract][Full Text] [Related]
22. A high-throughput screening system targeting the nuclear export pathway via the third nuclear export signal of influenza A virus nucleoprotein.
Kakisaka M; Mano T; Aida Y
Virus Res; 2016 Jun; 217():23-31. PubMed ID: 26948263
[TBL] [Abstract][Full Text] [Related]
23. Host Protein Moloney Leukemia Virus 10 (MOV10) Acts as a Restriction Factor of Influenza A Virus by Inhibiting the Nuclear Import of the Viral Nucleoprotein.
Zhang J; Huang F; Tan L; Bai C; Chen B; Liu J; Liang J; Liu C; Zhang S; Lu G; Chen Y; Zhang H
J Virol; 2016 Apr; 90(8):3966-3980. PubMed ID: 26842467
[TBL] [Abstract][Full Text] [Related]
24. Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus.
Liu G; Xiong S; Xiang YF; Guo CW; Ge F; Yang CR; Zhang YJ; Wang YF; Kitazato K
Arch Virol; 2011 Aug; 156(8):1359-69. PubMed ID: 21479599
[TBL] [Abstract][Full Text] [Related]
25. Single-chain intracellular antibodies inhibit influenza virus replication by disrupting interaction of proteins involved in viral replication and transcription.
Mukhtar MM; Li S; Li W; Wan T; Mu Y; Wei W; Kang L; Rasool ST; Xiao Y; Zhu Y; Wu J
Int J Biochem Cell Biol; 2009 Mar; 41(3):554-60. PubMed ID: 18687409
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation on construction and expression in vitro of nucleic acid vaccine of nucleoprotein of influenza virus A].
He JF; Fang SS; Cheng XW; Zhang R; Deng P; Zhao S
Wei Sheng Yan Jiu; 2005 Jul; 34(4):419-22. PubMed ID: 16229263
[TBL] [Abstract][Full Text] [Related]
27. Viral genome RNA degradation by sequence-selective, nucleic-acid hydrolyzing antibody inhibits the replication of influenza H9N2 virus without significant cytotoxicity to host cells.
Kim A; Lee JY; Byun SJ; Kwon MH; Kim YS
Antiviral Res; 2012 May; 94(2):157-67. PubMed ID: 22484663
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel compound with antiviral activity against influenza A virus depending on PA subunit of viral RNA polymerase.
Yamada K; Koyama H; Hagiwara K; Ueda A; Sasaki Y; Kanesashi SN; Ueno R; Nakamura HK; Kuwata K; Shimizu K; Suzuki M; Aida Y
Microbes Infect; 2012 Aug; 14(9):740-7. PubMed ID: 22441116
[TBL] [Abstract][Full Text] [Related]
29. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
[TBL] [Abstract][Full Text] [Related]
30. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
[TBL] [Abstract][Full Text] [Related]
31. Development of an anti-influenza drug screening assay targeting nucleoproteins with tryptophan fluorescence quenching.
Hung HC; Liu CL; Hsu JT; Horng JT; Fang MY; Wu SY; Ueng SH; Wang MY; Yaw CW; Hou MH
Anal Chem; 2012 Aug; 84(15):6391-9. PubMed ID: 22712523
[TBL] [Abstract][Full Text] [Related]
32. A nonimmunodominant nucleoprotein-derived peptide is presented by influenza A virus-infected H-2b cells.
Oukka M; Riché N; Kosmatopoulos K
J Immunol; 1994 May; 152(10):4843-51. PubMed ID: 8176207
[TBL] [Abstract][Full Text] [Related]
33. Development of an HTS assay for the search of anti-influenza agents targeting the interaction of viral RNA with the NS1 protein.
Maroto M; Fernandez Y; Ortin J; Pelaez F; Cabello MA
J Biomol Screen; 2008 Aug; 13(7):581-90. PubMed ID: 18594021
[TBL] [Abstract][Full Text] [Related]
34. Influenza A Virus Nucleoprotein: A Highly Conserved Multi-Functional Viral Protein as a Hot Antiviral Drug Target.
Hu Y; Sneyd H; Dekant R; Wang J
Curr Top Med Chem; 2017; 17(20):2271-2285. PubMed ID: 28240183
[TBL] [Abstract][Full Text] [Related]
35. The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses.
Kido H; Beppu Y; Imamura Y; Chen Y; Murakami M; Oba K; Towatari T
Biopolymers; 1999; 51(1):79-86. PubMed ID: 10380355
[TBL] [Abstract][Full Text] [Related]
36. [Clone expression and purification of influenza A virus nucleoprotein gene].
Fang SS; Cheng XW; Liu T; Liu JJ; Zhao SJ; Zhou L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):165-8. PubMed ID: 16027788
[TBL] [Abstract][Full Text] [Related]
37. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
Smith PW; Sollis SL; Howes PD; Cherry PC; Starkey ID; Cobley KN; Weston H; Scicinski J; Merritt A; Whittington A; Wyatt P; Taylor N; Green D; Bethell R; Madar S; Fenton RJ; Morley PJ; Pateman T; Beresford A
J Med Chem; 1998 Mar; 41(6):787-97. PubMed ID: 9526555
[TBL] [Abstract][Full Text] [Related]
38. Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome.
Turan K; Mibayashi M; Sugiyama K; Saito S; Numajiri A; Nagata K
Nucleic Acids Res; 2004; 32(2):643-52. PubMed ID: 14752052
[TBL] [Abstract][Full Text] [Related]
39. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
Taylor NR; Cleasby A; Singh O; Skarzynski T; Wonacott AJ; Smith PW; Sollis SL; Howes PD; Cherry PC; Bethell R; Colman P; Varghese J
J Med Chem; 1998 Mar; 41(6):798-807. PubMed ID: 9526556
[TBL] [Abstract][Full Text] [Related]
40. Assessment of retrovirus-expressed nucleoprotein as a vaccine against lethal influenza virus infections of chickens.
Brown DW; Kawaoka Y; Webster RG; Robinson HL
Avian Dis; 1992; 36(3):515-20. PubMed ID: 1329705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
